Go to the page content
KMI

Kontrollige oma KMI-d KMI kalkulaatoriga

Kehamassiindeks (KMI) on üks viis keha suuruse mõõtmiseks. See on vahend keharasva hindamiseks ja rasvumuse ja terviseriskide jälgimiseks. Seda saab arvutada KMI kalkulaatoriga ja see määratleb inimesi alakaalu, ülekaalu ja rasvumise järgi, lähtudes nende pikkusest ja kaalust. 

3 min lugemine

Leidke oma KMI ja terviseriskid

Meetermõõdustik Imperiaalne
Meetermõõdustik / Imperiaalne

KMI kalkulaator Vaadake oma KMI väärtust

Siin saate kasutada KMI kalkulaatorit, et jagada oma kaal kilogrammides oma pikkusega meetrites ja võrrelda oma tulemust KMI kategooriatega. Sisestage oma pikkus ja kaal ning kontrollige tulemusi allolevas tabelis. Lisainfo saamiseks klõpsake KMI kategoorial.

KategooriadBMI
Alakaaluline< 18,5
Normaalkaaluline18,5-24,9
Ülekaaluline25,0-29,9
Ülekaalulisus30 +
Rasvumine aste I30,0-34,9
Rasvumine aste II35,0-39,9
Rasvumine aste III> 40

* See KMI kalkulaator on mõeldud 20-aastastele ja vanematele täiskasvanutele. Kui olete alla 20-aastane, rääkige KMI-st oma arstiga.

 

Miks on KMI oluline teave?

KMI on hea viis kontrollida oma haiguste riski, mis on seotud keharasvaga. Ülekaalulisus või rasvumine on seotud suremuse ning mitmete haiguste või seisundite suurenenud riskiga. Üldiselt, mida suurem on teie KMI, seda suurem on võimalus, et arenevad välja muud kroonilised rasvumisega seotud haigused, nt:

  • 2. tüüpi diabeet
  • Südame-veresoonakonna haigus
  • Insult
  • Kõrge vererõhk
  • Viljatus
  • Depressioon ja ärevus
  • Pärgarteri haigus
  • Kõrge kolesterool
  • Mittealkohoolne rasvmaks / mittealkohoolne steatohepatiit
  •  Reflukshaigus
  • Metaboolne sündroom
  • Uriinipidamatus
  • Uneapnoe ja hingamisprobleemid
  • Krooniline neeruhaigus
  • Erinevad vähivormid: mh rinna-, käärsoole-, emakakeha-, söögitoru-, neeru-, munasarja- ja pankreasevähk
  • Põlveliigese osteoartriit
  • Sapikivid
  • Tromboos
  • Podagra
  • Suurenenud suremuse risk võrreldes inimestega, kel on tervislik KMI

Küsige oma arstilt lisateavet nende haiguste kohta ja selle kohta, kuidas need on seotud teie kehamassiindeksiga. Siit saatke lisateavet kaalulanguse kasulike mõjude kohta.

Millised on KMI piirid?

KMI on lihtne ja objektiivne mõõdik, kuid teatud juhtudel ja inimrühmades võib see olla eksitav. Uuringud on näidanud, et KMI on vähem täpne, kui sellega tuvastada haiguste riski inimestel, kes on vanemad, sportlased, pikad või lühikesed ja lihaselisemad. Näiteks tippsportlased või kulturistid on rohkem lihaselised ja kaaluvad rohkem, mis muudab nende KMI kõrgemaks.

KMI ei võta arvesse ka järgmist:

  • Pärilikud riskifaktorid, mis on seotud rasvumisega seotud haigustega, nagu metaboolne sündroom.
  • Keskkonna- ja elustiili tegurid peale rasvumise, mis võivad kaasa aidata kroonilise haiguse riskile.
  • Kuidas keharasv inimestel jaotub 

Oluline on meeles pidada, et suur kehakaal ei tähenda tingimata, et olete haige, nagu ka „normaalne“ kaal ei tähenda, et olete terve. Teie KMI ei määratle teid, kuid KMI tundmine ja mõistmine võib olla võimas vahend oma tervise eest hoolitsemisel.

Sõltumata teie KMI-st soovitavad tervishoiutöötajad tervislikku toitumist ja elustiili. Rääkige oma arstiga oma kehakaalust ja tervisest ning hinnake, milliseid meetmeid võib vaja minna. 
 

Viited
  • Rueda-Clausen, C F et al, “Assessment of People Living with Obesity,” Can. Adult Obes. Clin. Pract. Guidel., lk 1–17, 2020, [veebis]. Saadaval: http://obesitycanada.ca/wp-content/uploads/2020/09/6-Obesity-Assessment-v5-with-links.pdf
  • Yumuk, V et al, “European Guidelines for Obesity Management in Adults” Obes Facts. 2015 detsember; 8(6): 402–424. Avaldatud veebis 2015. aasta 5. detsembril. doi: 10.1159/000442721.
  • Garvey, W T et al, “American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.” Endocrine Practice 2016;22:1–203. DOI:https://doi.org/10.4158/EP161365.GL
  • Guh, D P et al, “The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis,” BMC Public Health, köide 9, nr 1, lk 88, 2009, doi: 10.1186/1471-2458-9-88.
  • Prospective Studies Collaboration, “Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies,” Lancet, köide 373, nr 9669, lk 1083–1096, märts 2009, doi: 10.1016/S0140-6736(09)60318-4.
  • “Obesity Screening – Medline Plus, U.S. National Library of Medicine” Saadaval: https://medlineplus.gov/lab-tests/obesity-screening/.
  • “Assessing Your Weight and Health Risk – National Heart, Lung, and Blood Association – U.S. Department of Health & Human Services” Saadaval: https://www.nhlbi.nih.gov/health/educational/lose_wt/risk.htm.
  • Hussain, Aet al,“Type 2 Diabetes and obesity: A review” Journal of Diabetology, juuni 2010; 2:1.
  • Katzmarzyk, P T et al, “Body mass index and risk of cardiovascular disease, cancer and all-cause mortality” Can. J. Public Health, köide 103, nr 2, lk 147–151, 2012, doi: 10.1007/BF03404221.
  • Kurth, T et al, “Prospective Study of Body Mass Index and Risk of Stroke in Apparently Healthy Women,” Circulation, köide 111, nr 15, lk 1992–1998, aprill 2005, doi: 10.1161/01.TSIR.0000161822.83163.B6.
  • Landi, Fet al,“Body Mass Index is Strongly Associated with Hypertension: Results from the Longevity Check-Up 7+ Study” Nutrients. 2018 detsember; 10(12): 1976. Avaldatud veebis 13. detsembril 2018. doi: 10.3390/nu10121976.
  • Dağ, Z Öet al,“Impact of obesity on infertility in women,”J. Turkish Ger. Gynecol. Assoc., köide 16, nr 2, lk 111–117, juuni 2015, doi: 10.5152/jtgga.2015.15232.
  • Moussa, O Met al,“Effect of body mass index on depression in a UK cohort of 363037 obese patients: A longitudinal analysis of transition,” Clin. Obes., köide 9, nr 3, lk e12305, juuni 2019, doi: https://doi.org/10.1111/cob.12305.
  • Zhao, G et al,“Depression and anxiety among US adults: associations with body mass index,”Int. J. Obes., köide 33, nr 2, lk 257–266, 2009, doi: 10.1038/ijo.2008.268.
  • Lamon-Fava, S et al, “Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women,” Arterioscler. Thromb. Vasc. Biol., köide 16, nr 12, lk 1509–1515 , detsember 1996, doi: 10.1161/01.ATV.16.12.1509.
  • Van Hemelrijck, M et al, “Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60 000 men and women in Sweden and Austria” Avaldatud: 13. juuni 2018https://doi.org/10.1371/journal.pone.0197830.
  • Loomis, A K et al, “Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies,”J. Clin. Endocrinol. Metab., köide 101, nr 3, lk 945–952, märts 2016, doi: 10.1210/jc.2015-3444.
  • Zafar, S et al,“Correlation of gastroesophageal reflux disease symptoms with body mass index,” Saudi J. Gastroenterol., köide 14, nr 2, lk 53–57, aprill 2008, doi: 10.4103/1319-3767.39618.
  • Han, T S et al,“A clinical perspective of obesity, metabolic syndrome and cardiovascular disease,”JRSM Cardiovasc. Dis., köide 5, lk 2048004016633371–2048004016633371, veebruar 2016, doi: 10.1177/2048004016633371.
  • Subak, L L et al, “Obesity and Urinary Incontinence: Epidemiology and Clinical Research Update” J Urol. 2009 detsember; 182(6 Suppl): S2–S7 doi: 10.1016/j.juro.2009.08.071
  • Romero-Corral, A et al, “Interactions Between Obesity and Obstructive Sleep Apnea - Implications for Treatment” Chest. 2010 märts; 137(3): 711–719. doi: 10.1378/chest.09-0360.
  • Herrington, W G et al, “Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1,4 million adults in England,” PLoS One, köide 12, nr 3, lk e0173515, märts 2017, [veebis]. Saadaval: https://doi.org/10.1371/journal.pone.0173515.
  • Bhaskaran, K et al, “Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5,24 million UK adults,” Lancet, köide 384, nr 9945, lk 755–765, august 2014, doi: 10.1016/S0140-6736(14)60892-8.
  • Zheng, H et al, “Body mass index and risk of knee osteoarthritis: Systematic review and meta-analysis of prospective studies,” BMJ Open, köide 5, nr 12, 2015, doi: 10.1136/bmjopen-2014-007568.
  • Su, Y P et al, “Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years” BMC Gastroenterol 19, 117 (2019). https://doi.org/10.1186/s12876-019-1032-y.
  • Yang, G et al, “The effects of obesity on venous thromboembolism: A review” Open J Prev Med. 2012 november; 2(4): 499–509. doi: 10.4236/ojpm.2012.24069.
  • Bai, L et al, “Incident gout and weight change patterns: a retrospective cohort study of US adults” Arthritis Res Ther. 2021; 23: 69. Avaldatud veebis 2021 2. märtsil . doi: 10.1186/s13075-021-02461-7
  • Klatsky, A L et al, “Body Mass Index and Mortality in a Very Large Cohort: Is It Really Healthier to Be Overweight?,” Perm. J., köide 21, lk 16–142, 2017, doi: 10.7812/TPP/16-142.
  • Heymsfield, S B et al, “Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review,” Obes. Rev., köide 17, nr 3, lk 262–275, märts 2016, doi: 10.1111/obr.12358.
  • “Ethnic Differences in BMI and Disease Risk | Obesity Prevention Source | Harvard T.H. Chan School of Public Health.” [Veebis]. Saadaval: https://www.hsph.harvard.edu/obesity-prevention-source/ethnic-differences-in-bmi-and-disease-risk/
  • Cossrow, N et al, “Race/Ethnic Issues in Obesity and Obesity-Related Comorbidities,” J. Clin. Endocrinol. Metab., köide 89, nr 6, lk 2590–2594, juuni 2004, doi: 10.1210/jc.2004-0339.
  • “Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies – Public Health – WHO international” Saadaval: https://www.who.int/nutrition/publications/bmi_asia_strategies.pdf.
  • Deurenberg-Yap, M et al, “The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore.” Int J Obes Relat Metab Disord. 2000 august; 24(8):1011-7. doi: 10.1038/sj.ijo.0801353. PMID: 10951540.
  • Valentino, G et al, “Body fat and its relationship with clustering of cardiovascular risk factors” Nutr Hosp. 2015;31(5):2253-2260 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318
  • Lear, S A et al, “Ethnic Variation in Fat and Lean Body Mass and the Association with INS Resistance” The Journal of Clinical Endocrinology & Metabolism, köide 94, väljaanne 12, 1. dets 2009, lk 4696–4702, https://doi.org/10.1210/jc.2009-1030.
  • Tillin, T et al, “The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study,” J. Am. Coll. Cardiol., köide 61, nr 17, lk 1777–1786, apr. 2013, doi: 10.1016/j.jacc.2012.12.046.
  • Tanne, D et al, “Body Fat Distribution and Long-Term Risk of Stroke Mortality” Stroke. Algselt avaldatud 31. märts 2005 https://doi.org/10.1161/01.STR.0000162584.39366.1c.
  • Chen, Y et al, “Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium,” BMJ Br. Med. J., köide 347, lk f5446, oktoober 2013, doi: 10.1136/bmj.f5446.
  • Wen, C P et al, “Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians” Public Health Nutrition, 12(4), 497-506. doi:10.1017/S1368980008002802.
  • J. S. for the S. of O. The Examination Committee of Criteria for `Obesity Disease’ in Japan, “New Criteria for `Obesity Disease’ in Japan,” Circ. J., köide 66, nr 11, lk 987–992, 2002, doi: 10.1253/circj.66.987.
  • Zheng, W et al, “Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians,” N. Engl. J. Med., köide 364, nr 8, lk 719–729, veeb. 2011, doi: 10.1056/NEJMoa1010679.
  • Aekplakorn, W et al, “Obesity indices and cardiovascular risk factors in Thai adults.” Int J Obes 30, 1782–1790 (2006). https://doi.org/10.1038/sj.ijo.0803346.
  • Choi, S E et al, “Do Risk Factors Explain the Increased Prevalence of Type 2 Diabetes Among California Asian Adults?” J Immigr Minor Health. 2011; 13(5): 803–808. Avaldatud internetis 9. oktoobril 2010. doi: 10.1007/s10903-010-9397-6
  • Swinburn, B et al, “Body size and composition in Polynesians” Int J Obes 23, 1178–1183 (1999). https://doi.org/10.1038/sj.ijo.0801053.
  • Young, D R et al, “Associations of overweight/obesity and socioeconomic status with hypertension prevalence across racial and ethnic groups,” J. Clin. Hypertens., köide 20, nr 3, lk 532–540, märts 2018, doi: https://doi.org/10.1111/jch.13217.
  • Maskarinec, G et al, “Diabetes Prevalence and Body Mass Index Differ by Ethnicity: The Multiethnic Cohort” Ethn Dis. 2009; 19(1): 49–55. PMCID: PMC2702477
  • Aleman-Mateo, H et al, “Elderly Mexicans have less muscle and greater total and truncel fat compared to African-Americans and Caucasians with the same BMI” J Nutr Health Aging. 2009 detsember; 13(10): 919. doi: 10.1007/s12603-009-0252-1
  • Cossrow, N et al, “Race/Ethnic Issues in Obesity and Obesity-Related Comorbidities” The Journal of Clinical Endocrinology & Metabolism, köide 89, väljaanne 6, 1. juuni 2004, lk 2590–2594, https://doi.org/10.1210/jc.2004-0339
  • Berber, A et al, “Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population,” Int. J. Obes., köide 25, nr 12, lk 1794–1799, 2001, doi: 10.1038/sj.ijo.0801827.
  • Chirinos, D A et al, “Defining Abdominal Obesity as a Risk Factor for Coronary Heart Disease in the U.S.: Results From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)” Diabetes Care, august 2020, 43 (8) 1774-1780; DOI: 10.2337/dc19-1855.
  • Elo, I T et al, “The Contribution of Weight Status to Black-White Differences in Mortality” Biodemography Soc Biol. 2017; 63(3): 206–220. doi: 10.1080/19485565.2017.1300519.
  • “9 The evidence | BMI: preventing ill health and premature death in black, Asian and other minority ethnic groups | Guidance | NICE.” [Veebis]. Saadaval: https://www.nice.org.uk/guidance/ph46/chapter/9-The-evidence.
  • Alammar, M et al, “Diagnostic Accuracy of Body Mass Index (BMI) When Diagnosing Obesity in a Saudi Adult Population in a Primary Care Setting, Cross Sectional, Retrospective Study” Diabetes Metab Syndr Obes. 2020; 13: 2515–2520. Avaldatud veebis 2020. aasta 14. juulil. doi: 10.2147/DMSO.S263063.
  • Bennet, L et al, “BMI and waist circumference cut-offs for corresponding levels of INS sensitivity in a Middle Eastern immigrant versus a native Swedish population – the MEDIM population based study” BMC Public Health. 2016; 16: 1242. Avaldatud veebis 2016. aasta 9. detsembril doi: 10.1186/s12889-016-3892-1
  • Al-Raddadi, R et al, “The prevalence of obesity and overweight, associated demographic and lifestyle factors, and health status in the adult population of Jeddah, Saudi Arabia,” Ther. Adv. Chronic Dis., köide 10, lk. 2040622319878997, jaanuar 2019, doi: 10.1177/2040622319878997.
  • Abell, J E et al, “Differences in Cardiovascular Disease Mortality Associated With Body Mass Between Black and White Persons,” Am. J. Public Health, köide 98, nr 1, lk 63–66, jaanuar 2008, doi: 10.2105/AJPH.2006.093781.
  • Batsis, J A et al, “Diagnostic Accuracy of Body Mass Index to Identify Obesity in Older Adults: NHANES 1999–2004” Int J Obes (Lond). 2016 mai; 40(5): 761–767. Avaldatud veebis 2015. aasta 1. detsembril doi: 10.1038/ijo.2015.243
  • Michigan State University. "BMI Not Accurate Indicator Of Body Fat, New Research Suggests." ScienceDaily. ScienceDaily, 7. märts 2007. Saadaval: www.sciencedaily.com/releases/2007/03/070305202535.htm
  • Sperrin, M et al, “Body mass index relates weight to height differently in women and older adults: serial cross-sectional surveys in England (1992-2011)”J. Public Health (Oxf)., köide 38, nr 3, lk 607–613, sept 2016, doi: 10.1093/pubmed/fdv067.
  • Weir CB, et al, “BMI Classification Percentile And Cut Off Points.” Kogumikus: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 jaanuar
  • “What Is My Ideal Body Fat Percentage? - Healthline” [veebis] Saadaval: https://www.healthline.com/health/exercise-fitness/ideal-body-fat-percentage
  • Nuttall, F Q. “Body Mass Index: Obesity, BMI, and Health: A Critical Review” Nutr Today. 2015 mai; 50(3): 117–128. Avaldatud veebis 2015. aasta 7. aprillil. doi: 10.1097/NT.0000000000000092.
  • Karastergiou, K et al, “Sex differences in human adipose tissues – the biology of pear shape,” Biol. Sex Differ., köide 3, nr 1, lk 13, 2012, doi: 10.1186/2042-6410-3-13.
  • Nauli, A M et al, “Why Do Men Accumulate Abdominal Visceral Fat?” Front. Physiol. , köide 10, lk 1486, detsember 2019, doi: 10.3389/fphys.2019.01486.
  • Thorpe Jr., R J et al, “Aging, Obesity, and Mortality: Misplaced Concern About Obese Older People?” Res Aging. 1. jaanuar 2004; 26(1): 108–129. doi: 10.1177/0164027503258738.
  • Yanovski, J A “Pediatric obesity. An introduction” Appetite. 1. oktoober 2015; 93: 3–12. Avaldatud veebis 30. märts 2015. doi: 10.1016/J.appet.2015.03.028
  • “About Child & Teen BMI – Center for Disease Control and Prevention” Saadaval: https://www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html.
  • Chung, S “Growth and Puberty in Obese Children and Implications of Body Composition” J Obes Metab Syndr. 2017 detsember; 26(4): 243–250. Avaldatud veebis 30. dets 2017. doi: 10.7570/jomes.2017.26.4.243
  • St-Onge, M P et al, “Body composition changes with aging: The cause or the result of alterations in metabolic rate and macronutrient oxidation?” Nutrition. 2010 veebruar; 26(2): 152–155. Avaldatud veebis 8. dets 2009. doi: 10.1016/J.nut.2009.07.004
  • Studenski, S A et al, “The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates,” J. Gerontol. A. Biol. Sci. Med. Sci., köide 69, nr 5, lk 547–558, mai 2014, doi: 10.1093/gerona/glu010.
  • McKee, A et al, “Obesity in the Elderly” Kogumikus: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.
  • Van Der Valk, E S et al, “A comprehensive diagnostic approach to detect underlying causes of obesity in adults” Obesity Reviews First published: 1. märts 2019 https://doi.org/10.1111/obr.12836
  • Hetherington-Rauth, M et al, “Comparison of direct measures of adiposity with indirect measures for assessing cardiometabolic risk factors in preadolescent girls” Nutr J. 2017; 16: 15. Avaldatud veebis 2017. aasta 23. veebruaril. doi: 10.1186/s12937-017-0236-7
  • Janssen, I et al, “Waist circumference and not body mass index explains obesity-related health risk” The American Journal of Clinical Nutrition, köide 79, väljaanne 3, märts 2004, lk 379–384, https://doi.org/10.1093/ajcn/79.3.379
  • Robert Ross et al, “Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity” Nat Rev Endocrinol. 2020; 16(3): 177–189. Avaldatud veebis 2020. aasta 4. veebruar doi: 10.1038/s41574-019-0310-7
  • “Why is my waist size important? - NHS.” [Veebis]. Saadaval: https://www.nhs.uk/common-health-questions/lifestyle/why-is-my-waist-size-important/.
  • “Metabolic syndrome - Symptoms and causes - Mayo Clinic.” [Veebis]. Saadaval: https://www.mayoclinic.org/diseases-conditions/metabolic-syndrome/symptoms-causes/syc-20351916
  • “Metabolic Syndrome – Cedars Sinai” [veebis]. Saadaval: https://www.cedars-sinai.org/health-library/diseases-and-conditions/m/metabolic-syndrome.html
  • “Metabolic Syndrome | NHLBI, NIH.” [Veebis]. Saadaval: https://www.nhlbi.nih.gov/health-topics/metabolic-syndrome
  • “HDL cholesterol: How to boost your ‘good’ cholesterol - Mayo Clinic.” [Veebis]. Saadaval: https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/hdl-cholesterol/art-20046388.
  • Yanai, H et al, “The underlying mechanisms for development of hypertension in the metabolic syndrome” Nutr J. 2008; 7: 10. Avaldatud veebis 2008. aasta 17. aprillil. doi: 10.1186/1475-2891-7-10.
  • “What is Cardiovascular Disease? | American Heart Association.” [Veebis]. Saadaval: https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease
  • “Type 2 Diabetes - Symptoms | ADA.” [Veebis]. Saadaval: https://www.diabetes.org/diabetes/type-2/symptoms.
  • Arenillas, J F et al, “The Metabolic Syndrome and Stroke - Potential Treatment Approaches” Stroke Algselt avaldatud 31. mail 2007 https://doi.org/10.1161/STROKEAHA.106.480004.
  • Lin, H et al, “The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article” Medicine (Baltimore). 2017 november; 96(47): e8838. Avaldatud veebis 27. nov 2017. doi: 10.1097/MD.0000000000008838.
  • Hinnouho, G M et al, “Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?,” Diabetes Care, köide 36, nr 8, lk 2294–2300, august 2013, doi: 10.2337/dc12-1654.
  • Eknoyan, G. “Adolphe Quetelet (1796–1874) — the average man and indices of obesity” Nephrology Dialysis Transplantation, köide 23, väljaanne 1, jaanuar 2008, lk 47–51, https://doi.org/10.1093/ndt/gfm517.
  • Abou Ziki, M D et al, “Metabolic Syndrome: Genetic Insights into Disease Pathogenesis” Curr Opin Lipidol. 2016 aprill; 27(2): 162–171. doi: 10.1097/MOL.0000000000000276
  • Kolb, H et al, “Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes.” BMC Med 15, 131 (2017). https://doi.org/10.1186/s12916-017-0901-x.
  • Jensen, M D “Role of Body Fat Distribution and the Metabolic Complications of Obesity” J Clin Endocrinol Metab. 2008 nov; 93(11 Suppl 1): S57–S63. doi: 10.1210/jc.2008-1585.
  • Wildman, R P et al, “The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes Among the US Population (NHANES 1999-2004),” Arch. Intern. Med., köide 168, nr 15, lk 1617–1624, august 2008, doi: 10.1001/archinte.168.15.1617.
  • Bhaskaran, K et al, “Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK” Lancet Diabetes Endocrinol. 2018 detsember; 6(12): 944–953. doi: 10.1016/S2213-8587(18)30288-2.
Kas see oli teile kasulik?

Teile võib ka meeldida

Kuidas mõista KMI-d
KMI | 5 min lugemine

Kuidas mõista KMI-d

Kehamassiindeks (KMI) on suurus, mis kehakaalu ja pikkuse kaudu määrab täiskasvanute alakaalulisuse, ülekaalulisuse ja rasvumise.

Kuidas leida rasvumisega võitlemisel parimaid liikumisviise?
Rasvumise ravimine | 4 min lugemine

Kuidas leida rasvumisega võitlemisel parimaid liikumisviise?

Regulaarne treenimine on kaalulangetuses väga oluline. Kehaline aktiivsus võib anda ka muid eeliseid, näiteks parandada kardiorespiratoorset vormi, liikuvust ja lisada jõudu. Lisaks aitab liikumine tõsta elukvaliteeti, parandades vaimset ja sotsiaalset heaolu.

Rohkem seotud artikleid